Please assess the completion status of the following clinical trial:

Trial Title: MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient suffering from Crohn's disease, ulcerative colitis, unclassifiable colitis or pouchitis.~* Disease needing to be treated by corticoids and/or immunosuppressive drugs.~* Infection by cytomegalovirus.~* New attack during the three previous months.~Exclusion Criteria:~* Serious or complicated attack, needing to be operated.~* Patient suffering from a psychiatric disease or is uncooperative.~* Patient suffering from another serious disease.~* Patient already participating in another clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).